Torrent Pharmaceuticals’ promoter is expected to sell a 2.9% share in the firm worth ₹3,000 Crore in a block auction on Wednesday. The promoter is set to issue 8.27 million shares at a discount of 6% per equity share over the current market price, according to reports.
This will include a greenshoe option of 1.65 lakh shares, which represents 0.5% of the equity.
According to the article, Kotak Securities and Citigroup will most likely serve as bankers for the Torrent Pharma transaction.
Torrent Pharma shares closed Tuesday’s session at ₹3,207 on the NSE, down ₹109.70 or 3.31% from Monday’s closing price.
Torrent Investments Private Limited is the company’s promoter, having a 71.25% interest as of September 30, 2024.
Torrent Pharmaceuticals reported a consolidated profit after tax (PAT) of ₹453 Crore in the September quarter, up 17% on strong domestic sales. The drug company declared a PAT of ₹386 Crore for the July-September period of the previous fiscal.
Torrent Pharmaceuticals said in a regulatory filing that revenues increased to ₹2,889 Crore during the reviewed period, up from ₹2,660 Crore the previous year.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice